What VertiFlex does

VertiFlex is a Carlsbad, California-based medical device company founded in 2005 that develops minimally invasive and motion-preserving spinal surgery technologies for the international healthcare market. The company's core offering addresses structural spinal pathologies — most notably lumbar spinal stenosis — through proprietary implants designed to decompress and stabilize the spine without resorting to traditional open fusion surgery, thereby preserving motion. The product platform is supported by a clinical evidence base including multiple Level 1 randomized controlled trials and real-world studies, and the technology has been commercialized across U.S. and international markets through specialty spine distribution channels targeting hospitals and ambulatory surgery centers.

VertiFlex's business model follows the conventional specialty medical device playbook: revenue is generated through hardware sales of capital equipment (implants and instrumentation) and associated procedure consumables to healthcare facilities, with specialist spine surgeons as the key prescribing decision-maker. The company funded its development and commercial scaling through 13 documented equity rounds between 2005 and 2017, aggregating approximately $170.4M, with a syndicate anchored by Aberdare Ventures, Alta Partners, Morgenthaler Ventures, and New Enterprise Associates. In 2019, VertiFlex was acquired by Boston Scientific, integrating the motion-preserving spinal technology platform into the acquirer's broader pain management and spinal surgery portfolio, which spans spinal cord stimulation (e.g., WaveWriter Alpha), basivertebral nerve ablation (Intracept), and radiofrequency ablation (G4 RF Generator) technologies distributed through enterprise field sales, ecommerce, and customer support infrastructure.

The note in the firmographics listing "10000+" employees appears to reflect the post-acquisition parent's headcount (Boston Scientific) rather than VertiFlex's standalone employee base, which is not separately disclosed in the source material. Leadership disclosure is limited to R. Stephen Reitzler, Vice President of Clinical & Regulatory Affairs, suggesting a lean management team consistent with a venture-backed commercial-stage device company that has now been absorbed into a larger strategic acquirer.

Name

VertiFlex

Website

https://vertiflex.com

Company type

Private

Founded year

2005

Headcount range

5,001–10,000 employees

Short description

VertiFlex is a Carlsbad, California-based medical device company founded in 2005 that develops minimally invasive, motion-preserving spinal surgery technologies for hospitals, ambulatory surgery centers, and spine surgeons in the U.S. and international markets, and is now part of Boston Scientific.

Ownership category

akta.pro rank

Product category

Spinal Surgery Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

akta.pro secondary industries

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Pain Management (Spine & Musculoskeletal) (HLAKALAM), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

• Minimally invasive spine surgery
• Spinal surgery technologies
• Motion preserving implants
• Interventional spine devices
• Spine medical devices

Headquarters

HQ city

Carlsbad

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Medical Device Sales: Boston Scientific generates revenue through the sale of medical devices including spinal cord stimulator systems, radiofrequency ablation generators and electrodes, and basivertebral nerve ablation systems. These are capital equipment and disposable medical devices sold to healthcare facilities and physicians.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

VertiFlex develops and provides minimally invasive and motion-preserving spinal surgery technologies to the international healthcare market. The company's offerings target interventional spine procedures intended to treat spinal conditions while preserving natural motion, sold to healthcare facilities and specialist physicians.

Product overview

The source data does not contain information about VertiFlex. The extracted content describes Boston Scientific's pain management portfolio consisting of: the WaveWriter Alpha™ Spinal Cord Stimulator System for spinal cord stimulation therapy treating conditions like FBSS, DPN, CRPS, and radiculopathy; the Intracept™ Procedure for basivertebral nerve ablation targeting vertebrogenic pain; the G4™ RF Generator for radiofrequency ablation procedures; and the Spinal Cord Stimulator Systems family with ImageReady™ MRI conditionality. The Nalu Neurostimulation System was acquired from Nalu Medical and integrated into the product family. These products address chronic pain through spinal cord stimulation, intraosseous nerve ablation, and radiofrequency ablation technologies.

Differentiator

Problem solved

Functional benefit

Products and services

• Minimally invasive spinal surgery technologies

Quantifiable outcome

• Significant pain relief and function improvements sustained more than 5 years after a single Intracept Procedure treatment
• +2 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Nalu MedicalcoreStrategic or Co-development Partner · 17 October 2025Nalu Medical, a company specializing in neurostimulation technology, has been acquired by Boston Scientific. The acquisition announced October 17, 2025, brings Nalu's neurostimulation system into the Boston Scientific portfolio. Nalu Medical's neurostimulation technology is now integrated under the Boston Scientific brand, expanding their pain management offerings with an additional spinal cord stimulation platform.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• SI-BONE: Specialist in minimally invasive sacroiliac joint fusion. Comparable as a smaller, focused spine device company addressing adjacent indications with MIS technology.
• Vertos Medical: Developer of minimally invasive lumbar decompression (mild procedure) for lumbar spinal stenosis. Directly comparable to VertiFlex as a small MIS-spine specialist targeting the same stenosis patient population.
• Relievant Medsystems: Developer of the Intracept basivertebral nerve ablation procedure — the exact platform appearing in VertiFlex's source technology data. Highly comparable in indication and clinical positioning, now part of Boston Scientific.

Direct peers

• Globus Medical: Spine-focused medical-device company with extensive MIS and motion-preservation portfolio following its NuVasive merger. Directly comparable product mix, customer base, and growth orientation.
• NuVasive (now Globus Medical): Pure-play spine specialist with deep MIS and motion-preservation offerings. Closely comparable business model, customer base (spine surgeons, hospitals), and product mix to VertiFlex.
• Orthofix Medical: Spine and orthopedics specialist with motion-preservation and biologic offerings. Comparable as a mid-size spine specialist targeting similar hospital and surgeon customers.
• Alphatec Holdings: Pure-play spine company focused on MIS approaches for deformity and degenerative conditions. Comparable business model and product strategy targeting spine surgeons.

Broad incumbents

• Boston Scientific: Major diversified medical-device company that has acquired multiple MIS-spine and pain-management assets (including Relievant Medsystems' Intracept platform). Comparable due to overlapping presence in spinal cord stimulation, basivertebral nerve ablation, and RF ablation — directly the categories surfaced in VertiFlex's source data.
• Stryker: Diversified medtech with a Spine division offering MIS and cervical/lumbar fixation. Comparable as a broad incumbent overlapping VertiFlex's MIS spine category.
• Medtronic: Largest spine medical-device manufacturer with broad portfolios in MIS, motion-preservation, and spinal cord stimulation. Comparable as a direct competitor across VertiFlex's stated minimally invasive and motion-preserving spine categories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/vertiflexinc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds13 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VertiFlex